Current News
Country:
Operation:
Search for:
Overview Companies Countries Top News Tag Clouds
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Products   Research   Technology

Contact | Print version | PDF version | Send article | RSS-FeedRSS-Feed

Crucell Announces STAR Research License Agreement with Celltrion, Inc.

10 Apr 2008 - Crucell N.V. announced a non-exclusive STARŪ research license agreement with Celltrion, Inc. for the production of recombinant proteins. Under the agreement, Celltrion will evaluate Crucell's STARŪ technology for generating cell lines for the manufacture of biopharmaceuticals. Financial details of the agreement were not disclosed.
 
Contact / Request Information
Additional information

Celltrion, Inc
Incheon, Korea, Republic of (South Korea)

News
- 23 Jul 2008 - MediGene exercises option for Anti-L1 Monoclonal Antibody and continues collaboration with DKFZ (German Cancer Research Center)
- 09 Feb 2006 - Aphton to Expand Licensing and Commercialization Agreements Into Europe for two Antibodies
 

Crucell N.V.
Leiden, Netherlands

Company
- Buyer's Guide entry of Crucell N.V.
 
News
- 26 Jun 2008 - DSM and Crucell Sign Agreement with Avid Bioservices to Serve as U.S. Contract Manufacturer of PER.C6 Cell Line Proteins
- 17 Jun 2008 - DSM and Crucell Announce Record Achievement in PER.C6 Technology
- 21 May 2008 - Crucell Announces Research License Agreement with Bioceros on STAR Technology
 more news

News regarding Business
MyBionity.COM
Newsletter Subscription
Your e-mail:
Top  
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET